Takasuke Muk AI Yama
About Takasuke Muk AI Yama
Takasuke Muk AI Yama serves as a Senior Scientist II at Erasca, Inc. in San Diego, California, where he has worked since 2022. He has extensive experience in the biotechnology field, having held various research positions at notable organizations including eFFECTOR Therapeutics and Pfizer.
Work at Erasca
Takasuke Muk AI Yama has been employed at Erasca, Inc. as a Senior Scientist II since 2022. In this role, he contributes to the company's research initiatives in the biotechnology sector. His tenure at Erasca spans two years, during which he has been involved in various projects aimed at advancing cancer therapies. The company is located in San Diego, California, where he continues to apply his expertise in scientific research.
Education and Expertise
Takasuke Muk AI Yama holds multiple degrees in the field of science. He earned a Bachelor of Science (B.S.) from Tokyo University of Science from 1999 to 2003. He then pursued a Master of Science (M.S.) at the same institution from 2003 to 2005. He completed his academic journey with a Doctor of Philosophy (Ph.D.) from Tohoku University, which he attended from 2011 to 2014. His educational background provides a strong foundation for his work in scientific research.
Background
Takasuke Muk AI Yama has a diverse professional background in scientific research. He began his career at Pfizer, where he worked as a Senior Associate Scientist from 2005 to 2007 and later as a Scientist from 2007 to 2011. After his time at Pfizer, he served as a Research Associate at The Scripps Research Institute from 2014 to 2016. He also gained international experience as an Academic Guest at ETH Zurich in 2012. His roles at eFFECTOR Therapeutics, Inc. included positions as Research Scientist I and II from 2016 to 2019.
Professional Experience
Takasuke Muk AI Yama has accumulated significant professional experience in the biotechnology and pharmaceutical industries. His roles have included positions at Pfizer and eFFECTOR Therapeutics, Inc., where he focused on research and development. His experience spans over a decade, with a strong emphasis on scientific research and innovation. His work has involved various aspects of drug development and therapeutic research.